425 related articles for article (PubMed ID: 21726676)
1. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo.
Rhee Y; Bivi N; Farrow E; Lezcano V; Plotkin LI; White KE; Bellido T
Bone; 2011 Oct; 49(4):636-43. PubMed ID: 21726676
[TBL] [Abstract][Full Text] [Related]
2. PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.
Rhee Y; Allen MR; Condon K; Lezcano V; Ronda AC; Galli C; Olivos N; Passeri G; O'Brien CA; Bivi N; Plotkin LI; Bellido T
J Bone Miner Res; 2011 May; 26(5):1035-46. PubMed ID: 21140374
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone receptor signaling induces bone resorption in the adult skeleton by directly regulating the RANKL gene in osteocytes.
Ben-awadh AN; Delgado-Calle J; Tu X; Kuhlenschmidt K; Allen MR; Plotkin LI; Bellido T
Endocrinology; 2014 Aug; 155(8):2797-809. PubMed ID: 24877630
[TBL] [Abstract][Full Text] [Related]
4. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
Sapir-Koren R; Livshits G
Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227
[TBL] [Abstract][Full Text] [Related]
5. Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes.
Rhee Y; Lee EY; Lezcano V; Ronda AC; Condon KW; Allen MR; Plotkin LI; Bellido T
J Biol Chem; 2013 Oct; 288(41):29809-20. PubMed ID: 23963454
[TBL] [Abstract][Full Text] [Related]
6. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling.
Martin A; Liu S; David V; Li H; Karydis A; Feng JQ; Quarles LD
FASEB J; 2011 Aug; 25(8):2551-62. PubMed ID: 21507898
[TBL] [Abstract][Full Text] [Related]
7. Control of Bone Anabolism in Response to Mechanical Loading and PTH by Distinct Mechanisms Downstream of the PTH Receptor.
Delgado-Calle J; Tu X; Pacheco-Costa R; McAndrews K; Edwards R; Pellegrini GG; Kuhlenschmidt K; Olivos N; Robling A; Peacock M; Plotkin LI; Bellido T
J Bone Miner Res; 2017 Mar; 32(3):522-535. PubMed ID: 27704638
[TBL] [Abstract][Full Text] [Related]
8. Attenuated Dentin Matrix Protein 1 Enhances Fibroblast Growth Factor 23 in Calvaria in a Primary Hyperparathyroidism Model.
Nagata Y; Imanishi Y; Ohara M; Maeda-Tateishi T; Miyaoka D; Hayashi N; Kurajoh M; Emoto M; Inaba M
Endocrinology; 2019 May; 160(5):1348-1358. PubMed ID: 30916761
[TBL] [Abstract][Full Text] [Related]
9. Osteocyte-specific deletion of Fgfr1 suppresses FGF23.
Xiao Z; Huang J; Cao L; Liang Y; Han X; Quarles LD
PLoS One; 2014; 9(8):e104154. PubMed ID: 25089825
[TBL] [Abstract][Full Text] [Related]
10. Sclerostin Directly Stimulates Osteocyte Synthesis of Fibroblast Growth Factor-23.
Ito N; Prideaux M; Wijenayaka AR; Yang D; Ormsby RT; Bonewald LF; Atkins GJ
Calcif Tissue Int; 2021 Jul; 109(1):66-76. PubMed ID: 33616712
[TBL] [Abstract][Full Text] [Related]
11. Fgf23 and parathyroid hormone signaling interact in kidney and bone.
Andrukhova O; Streicher C; Zeitz U; Erben RG
Mol Cell Endocrinol; 2016 Nov; 436():224-39. PubMed ID: 27498418
[TBL] [Abstract][Full Text] [Related]
12. Autocrine and Paracrine Regulation of the Murine Skeleton by Osteocyte-Derived Parathyroid Hormone-Related Protein.
Ansari N; Ho PW; Crimeen-Irwin B; Poulton IJ; Brunt AR; Forwood MR; Divieti Pajevic P; Gooi JH; Martin TJ; Sims NA
J Bone Miner Res; 2018 Jan; 33(1):137-153. PubMed ID: 28914969
[TBL] [Abstract][Full Text] [Related]
13. Convergent Signaling Pathways Regulate Parathyroid Hormone and Fibroblast Growth Factor-23 Action on NPT2A-mediated Phosphate Transport.
Sneddon WB; Ruiz GW; Gallo LI; Xiao K; Zhang Q; Rbaibi Y; Weisz OA; Apodaca GL; Friedman PA
J Biol Chem; 2016 Sep; 291(36):18632-42. PubMed ID: 27432882
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone 1 receptor is essential to induce FGF23 production and maintain systemic mineral ion homeostasis.
Fan Y; Bi R; Densmore MJ; Sato T; Kobayashi T; Yuan Q; Zhou X; Erben RG; Lanske B
FASEB J; 2016 Jan; 30(1):428-40. PubMed ID: 26428657
[TBL] [Abstract][Full Text] [Related]
15. Calcium fluxes at the bone/plasma interface: Acute effects of parathyroid hormone (PTH) and targeted deletion of PTH/PTH-related peptide (PTHrP) receptor in the osteocytes.
Dedic C; Hung TS; Shipley AM; Maeda A; Gardella T; Miller AL; Divieti Pajevic P; Kunkel JG; Rubinacci A
Bone; 2018 Nov; 116():135-143. PubMed ID: 30053608
[TBL] [Abstract][Full Text] [Related]
16. Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice.
Murali SK; Andrukhova O; Clinkenbeard EL; White KE; Erben RG
PLoS Biol; 2016 Apr; 14(4):e1002427. PubMed ID: 27035636
[TBL] [Abstract][Full Text] [Related]
17. Growth-related skeletal changes and alterations in phosphate metabolism.
Michigami T; Tachikawa K; Yamazaki M; Nakanishi T; Kawai M; Ozono K
Bone; 2022 Aug; 161():116430. PubMed ID: 35577326
[TBL] [Abstract][Full Text] [Related]
18. The fibroblast growth factor receptor mediates the increased FGF23 expression in acute and chronic uremia.
Hassan A; Durlacher K; Silver J; Naveh-Many T; Levi R
Am J Physiol Renal Physiol; 2016 Feb; 310(3):F217-21. PubMed ID: 26311115
[TBL] [Abstract][Full Text] [Related]
19. Phosphate-dependent FGF23 secretion is modulated by PiT2/Slc20a2.
Bon N; Frangi G; Sourice S; Guicheux J; Beck-Cormier S; Beck L
Mol Metab; 2018 May; 11():197-204. PubMed ID: 29551636
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
